Your browser doesn't support javascript.
loading
Ponatinib sensitizes myeloma cells to MEK inhibition in the high-risk VQ model.
Flietner, Evan; Wen, Zhi; Rajagopalan, Adhithi; Jung, Oisun; Watkins, Lyndsay; Wiesner, Joshua; You, Xiaona; Zhou, Yun; Sun, Yuqian; Kingstad-Bakke, Brock; Callander, Natalie S; Rapraeger, Alan; Suresh, M; Asimakopoulos, Fotis; Zhang, Jing.
Afiliação
  • Flietner E; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Room 7453, WIMR II, 1111 Highland Avenue, Madison, WI, 53705, USA.
  • Wen Z; Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53705, USA.
  • Rajagopalan A; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Room 7453, WIMR II, 1111 Highland Avenue, Madison, WI, 53705, USA.
  • Jung O; Center for Precision Medicine Research and Integrated Research and Development Laboratories, Marshfield Clinic Research Institute, Marshfield, WI, 54449, USA.
  • Watkins L; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Room 7453, WIMR II, 1111 Highland Avenue, Madison, WI, 53705, USA.
  • Wiesner J; Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, 1111 Highland Avenue, Madison, WI, 53705, USA.
  • You X; Center for Precision Medicine Research and Integrated Research and Development Laboratories, Marshfield Clinic Research Institute, Marshfield, WI, 54449, USA.
  • Zhou Y; Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, 53706, USA.
  • Sun Y; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Room 7453, WIMR II, 1111 Highland Avenue, Madison, WI, 53705, USA.
  • Kingstad-Bakke B; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Room 7453, WIMR II, 1111 Highland Avenue, Madison, WI, 53705, USA.
  • Callander NS; Department of Biology, College of Agricultural and Life Sciences, University of Wisconsin-Madison, Madison, WI, 53706, USA.
  • Rapraeger A; Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
  • Suresh M; Division of Hematology/Oncology, Department of Medicine, UW Comprehensive Cancer Center, University of Wisconsin-Madison, Madison, WI, 53705, USA.
  • Asimakopoulos F; Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, 1111 Highland Avenue, Madison, WI, 53705, USA.
  • Zhang J; Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
Sci Rep ; 12(1): 10616, 2022 06 23.
Article em En | MEDLINE | ID: mdl-35739276
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article